Copyright
©2014 Baishideng Publishing Group Inc.
World J Hepatol. Nov 27, 2014; 6(11): 818-824
Published online Nov 27, 2014. doi: 10.4254/wjh.v6.i11.818
Published online Nov 27, 2014. doi: 10.4254/wjh.v6.i11.818
Table 2 Tumor-related characteristics (n = 30)
| Parameter | Number (%) | |
| AFP level (0-10) | Normal | 4 (13.4%) |
| Elevated | 26 (86.6%) | |
| PS | PS 0 | 24 (80) |
| PS 1-2 | 4 (13.4) | |
| PS > 2 | 2 (6) | |
| BCLC | Stage 0 | 0 (0) |
| Stage A | 1 (3.8) | |
| Stage B | 19 (73.1) | |
| Stage C | 4 (15.4) | |
| Stage D | 2 (7.7) | |
| Number of focal lesions | Single | 17 (56.7) |
| Multiple | 13 (43.4) | |
| Site of focal lesions | Right lobe | 18 (60) |
| Left lobe | 5 (16.7) | |
| Both | 7 (23.3) | |
| Tumor size by CT | < 3 cm | 1 (3.3) |
| 3-5 cm | 12 (40) | |
| > 5 cm | 17 (56.7) | |
| Portal vein invasion | Yes | 7 (23.3) |
| No | 23 (76.7) |
- Citation: El-Garem H, Ammer A, Shehab H, Shaker O, Anwer M, El-Akel W, Omar H. Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma. World J Hepatol 2014; 6(11): 818-824
- URL: https://www.wjgnet.com/1948-5182/full/v6/i11/818.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i11.818